Delivery Order SPE2DB22D2214-SPE2DB25FS6HL
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $2,872.80 by the Department of Defense Medical Supply Chain on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation. This award is issued under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $19,039.16 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the supply of Ondansetron Orally Disintegrating Tablet 8 mg in quantities of 30 tablets. This firm fixed-price delivery order, which is not set-aside, represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,013.50 for Ondansetron Orally Disintegrating Tablets 8mg (30-count supply) on August 21, 2025, with completion targeted for September 18, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,328.04 under firm fixed-price terms, with an ultimate completion date of July 31, 2025. The pharmaceutical products will be delivered to the contracting location in Conshohocken, Pennsylvania, where...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $6,374.02 and an ultimate completion date of August 14, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $13,637.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package, with a ceiling value of $1,726.44. This firm fixed-price delivery order, which is set to be completed by August 5, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply role under its larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract does not carry a set-aside...
- AmerisourceBergen Drug Corp received a $1,615.95 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for Ondansetron ODT 8 mg tablets (30-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of August 20, 2025, and represents a child order under the company's larger contract vehicle with DLA. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $7,069.80 and an ultimate completion date of July 23, 2025. The contract carries no set-aside designation and represents a competitively awarded transaction. Performance will be executed from the contractor's location in Conshohocken,...